Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
December-2022 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2022 Volume 24 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Open Access

Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review)

Corrigendum in: /10.3892/etm.2023.11885
  • Authors:
    • Zixin Chen
    • Limei Shao
    • Mingfeng Jiang
    • Xuejiao Ba
    • Bingjie Ma
    • Tao Zhou
  • View Affiliations / Copyright

    Affiliations: Department of Clinical Laboratory, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650500, P.R. China, Institute of Microbiological Detection and Analyses, Sichuan Center for Disease Control and Prevention, Chengdu, Sichuan, 610044, P.R. China
    Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 707
    |
    Published online on: October 4, 2022
       https://doi.org/10.3892/etm.2022.11643
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Over past few decades, diabetes has become widespread on a global scale. Hemoglobin A1c (HbA1c) assessment is crucial for diabetes care, since it allows for the monitoring of an individual's level of glycemic control over the course of 2 to 3 months and risk assessment to determine any possible complications. Numerous methods, including cation‑exchange chromatography, electrophoresis, immunoassays and affinity chromatography, can be used to determine the HbA1c level. Each method has its limitations, however. The amount of HbA1c in patient samples is not only dependent on blood glucose levels, but is also strongly influenced by changes in red blood cell lifespan and globin chain structure. Consequently, hematological, clinical biochemistry and analytical methods all intertwine when interpreting HbA1c. There are numerous reports on the interactions of HbA1c with inherited and acquired diseases. Some of these impacts are inconsistent and difficult to explain. The present review article aimed to summarize and classify these effects and evaluate their clinical relevance. The findings discussed herein may serve as a reminder that clinical HbA1c values need to be analyzed with caution.
View Figures

Figure 1

Figure 2

View References

1 

Emerging Risk Factors Collaboration. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, et al: Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet. 375:2215–2222. 2010.PubMed/NCBI View Article : Google Scholar

2 

Diabetes Control and Complications Trial Research Group. Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L and Siebert C: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 329:977–986. 1993.PubMed/NCBI View Article : Google Scholar

3 

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK prospective diabetes study (UKPDS) group. Lancet. 352:837–853. 1998.PubMed/NCBI

4 

American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2021. Diabetes Care. 44 (Suppl 1):S15–S33. 2021.PubMed/NCBI View Article : Google Scholar

5 

Weykamp C, John WG, Mosca A, Hoshino T, Little R, Jeppsson JO, Goodall I, Miedema K, Myers G, Reinauer H, et al: The IFCC reference measurement system for HbA1c: A 6-year progress report. Clin Chem. 54:240–248. 2008.PubMed/NCBI View Article : Google Scholar

6 

Bunn HF: Evaluation of glycosylated hemoglobin diabetic patients. Diabetes. 30:613–617. 1981.PubMed/NCBI View Article : Google Scholar

7 

Mossine VV and Mawhinney TP: 1-Amino-1-deoxy-D-fructose (‘fructosamine’) and its derivatives. Adv Carbohydr Chem Biochem. 64:291–402. 2010.PubMed/NCBI View Article : Google Scholar

8 

Shapiro R, McManus MJ, Zalut C and Bunn HF: Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem. 255:3120–3127. 1980.PubMed/NCBI

9 

Harris NS, Weaver KD, Beal SG and Winter WE: The interaction between Hb A1C and selected genetic factors in the African American population in the USA. J Appl Lab Med. 6:167–179. 2021.PubMed/NCBI View Article : Google Scholar

10 

Weykamp C: HbA1c: A review of analytical and clinical aspects. Ann Lab Med. 33:393–400. 2013.PubMed/NCBI View Article : Google Scholar

11 

Ang SH, Thevarajah M, Alias Y and Khor SM: Current aspects in hemoglobin A1c detection: A review. Clin Chim Acta. 439:202–211. 2015.PubMed/NCBI View Article : Google Scholar

12 

Rhea JM and Molinaro R: Pathology consultation on HbA(1c) methods and interferences. Am J Clin Pathol. 141:5–16. 2014.PubMed/NCBI View Article : Google Scholar

13 

Jaisson S, Leroy N, Meurice J, Guillard E and Gillery P: First evaluation of Capillarys 2 Flex Piercing® (Sebia) as a new analyzer for HbA1c assay by capillary electrophoresis. Clin Chem Lab Med. 50:1769–1775. 2012.PubMed/NCBI View Article : Google Scholar

14 

Teodoro-Morrison T, Janssen MJ, Mols J, Hendrickx BH, Velmans MH, Lotz J, Lackner K, Lennartz L, Armbruster D, Maine G and Yip PM: Evaluation of a next generation direct whole blood enzymatic assay for hemoglobin A1c on the ARCHITECT c8000 chemistry system. Clin Chem Lab Med. 53:125–132. 2015.PubMed/NCBI View Article : Google Scholar

15 

Little RR, Rohlfing CL, Hanson S, Connolly S, Higgins T, Weykamp CW, D'Costa M, Luzzi V, Owen WE and Roberts WL: Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods. Clin Chem. 54:1277–1282. 2008.PubMed/NCBI View Article : Google Scholar

16 

Yun YM, Ji M, Ko DH, Chun S, Kwon GC, Lee K, Song SH, Seong MW, Park SS and Song J: Hb variants in Korea: Effect on HbA1c using five routine methods. Clin Chem Lab Med. 55:1234–1242. 2017.PubMed/NCBI View Article : Google Scholar

17 

Xu A, Chen W, Xia Y, Zhou Y and Ji L: Effects of common hemoglobin variants on HbA1c measurements in China: Results for α- and β-globin variants measured by six methods. Clin Chem Lab Med. 56:1353–1361. 2018.PubMed/NCBI View Article : Google Scholar

18 

Rohlfing CL, Connolly SM, England JD, Hanson SE, Moellering CM, Bachelder JR and Little RR: The effect of elevated fetal hemoglobin on hemoglobin A1c results: Five common hemoglobin A1c methods compared with the IFCC reference method. Am J Clin Pathol. 129:811–814. 2008.PubMed/NCBI View Article : Google Scholar

19 

Chachou A, Randoux C, Millart H, Chanard J and Gillery P: Influence of in vivo hemoglobin carbamylation on HbA1c measurements by various methods. Clin Chem Lab Med. 38:321–326. 2000.PubMed/NCBI View Article : Google Scholar

20 

Weykamp C, Kemna E, Leppink S and Siebelder C: Glycation rate of haemoglobins S, C, D, E, J and G, and analytical interference on the measurement of HbA1c with affinity chromatography and capillary electrophoresis. Clin Chem Lab Med. 53:e207–e210. 2015.PubMed/NCBI View Article : Google Scholar

21 

Coban E, Ozdogan M and Timuragaoglu A: Effect of iron deficiency anemia on the levels of hemoglobin A1c in nondiabetic patients. Acta Haematol. 112:126–128. 2004.PubMed/NCBI View Article : Google Scholar

22 

Koga M, Morita S, Saito H, Mukai M and Kasayama S: Association of erythrocyte indices with glycated haemoglobin in pre-menopausal women. Diabet Med. 24:843–847. 2007.PubMed/NCBI View Article : Google Scholar

23 

Son JI, Rhee SY, Woo JT, Hwang JK, Chin SO, Chon S, Oh S, Kim SW and Kim YS: Hemoglobin a1c may be an inadequate diagnostic tool for diabetes mellitus in anemic subjects. Diabetes Metab J. 37:343–348. 2013.PubMed/NCBI View Article : Google Scholar

24 

Thom CS, Dickson CF, Gell DA and Weiss MJ: Hemoglobin variants: Biochemical properties and clinical correlates. Cold Spring Harb Perspect Med. 3(a011858)2013.PubMed/NCBI View Article : Google Scholar

25 

Dessi M, Pieri M, Pignalosa S, Martino FG and Zenobi R: Performances of capillary electrophoresis and HPLC methods in HbA1c determination: Diagnostic accuracy in HbS and HbD-Iran variants' presence. J Clin Lab Anal. 29:57–60. 2015.PubMed/NCBI View Article : Google Scholar

26 

Suo M, Wen D, Wang W, Zhang D, Xu S, Wang X and Hu T: False measurement of glycated hemoglobin in patients without hemoglobin A. Biosci Rep. 39(BSR20180128)2019.PubMed/NCBI View Article : Google Scholar

27 

Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D and Heine RJ: A1c-Derived Average Glucose Study Group. Translating the A1C assay into estimated average glucose values. Diabetes Care. 31:1473–1478. 2008.PubMed/NCBI View Article : Google Scholar

28 

Franco RS: Measurement of red cell lifespan and aging. Transfus Med Hemother. 39:302–307. 2012.PubMed/NCBI View Article : Google Scholar

29 

Goldstein DE, Little RR, Lorenz RA, Malone JI, Nathan D, Peterson CM and Sacks DB: Tests of glycemia in diabetes. Diabetes Care. 27:1761–1773. 2004.PubMed/NCBI View Article : Google Scholar

30 

Piel FB, Howes RE, Patil AP, Nyangiri OA, Gething PW, Bhatt S, Williams TN, Weatherall DJ and Hay SI: The distribution of haemoglobin C and its prevalence in newborns in Africa. Sci Rep. 3(1671)2013.PubMed/NCBI View Article : Google Scholar

31 

Ouzzif Z, El Maataoui A, Oukhedda N, Messaoudi N, Mikdam M, Abdellatifi M and Doghmi K: Hemoglobinosis C in Morocco : A report of 111 cas. Tunis Med. 95:229–233. 2017.PubMed/NCBI

32 

Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF and Vichinsky EP: Sickle cell disease. Nat Rev Dis Primers. 4(18010)2018.PubMed/NCBI View Article : Google Scholar

33 

Piel FB, Steinberg MH and Rees DC: Sickle cell disease. N Engl J Med. 376:1561–1573. 2017.PubMed/NCBI View Article : Google Scholar

34 

Lacy ME, Wellenius GA, Sumner AE, Correa A, Carnethon MR, Liem RI, Wilson JG, Sacks DB, Jacobs DR Jr, Carson AP, et al: Association of sickle cell trait with hemoglobin A1c in African Americans. JAMA. 317:507–515. 2017.PubMed/NCBI View Article : Google Scholar

35 

Qiu CC, Kasten-Jolly J and Abraham EC: Human red cell acetyltransferase. Life Sci. 42:2739–2748. 1988.PubMed/NCBI View Article : Google Scholar

36 

Chen D, Crimmins DL, Hsu FF, Lindberg FP and Scott MG: Hemoglobin Raleigh as the cause of a falsely increased hemoglobin A1C in an automated ion-exchange HPLC method. Clin Chem. 44:1296–1301. 1998.PubMed/NCBI

37 

Koga M, Inada S, Shimizu S, Hatazaki M, Umayahara Y and Nishihara E: Aldimine formation reaction, the first step of the maillard early-phase reaction, might be enhanced in variant Hemoglobin, Hb Himeji. Ann Clin Lab Sci. 45:643–649. 2015.PubMed/NCBI

38 

Bissé E, Schauber C, Zorn N, Epting T, Eigel A, Van Dorsselaer A, Wieland H, Kister J and Kiger L: Hemoglobin Görwihl [alpha2beta(2)5(A2)Pro->Ala], an electrophoretically silent variant with impaired glycation. Clin Chem. 49:137–143. 2003.PubMed/NCBI View Article : Google Scholar

39 

Nakanishi T, Miyazaki A, Kishikawa M, Shimizu A, Aoki K and Kikuchi M: Hb Sagami [beta 139(H17)Asn->Thr]: A new hemoglobin variant not detected by isoelectrofocusing and propan-2-ol test, was detected by electrospray ionization mass spectrometry. J Mass Spectrom. 33:565–569. 1998.

40 

Kabytaev K, Connolly S, Rohlfing CL, Sacks DB, Stoyanov AV and Little RR: Higher degree of glycation of hemoglobin S compared to hemoglobin A measured by mass spectrometry: Potential impact on HbA1c testing. Clin Chim Acta. 458:40–43. 2016.PubMed/NCBI View Article : Google Scholar

41 

Watanabe T, Kato K, Yamada D, Midorikawa S, Sato W, Shiga M, Otsuka Y, Miura M, Harano K and Harano T: A nondiabetic case of hemoglobin variant (Hb Niigata) with inappropriately high and low HbA1c titers detected by different methods. Clin Chem. 44:1562–1564. 1998.PubMed/NCBI

42 

Shah SC, Malone JI, Boissel JP and Kasper TJ: Hemoglobin South Florida. New variant with normal electrophoretic pattern mistaken for glycosylated hemoglobin. Diabetes. 35:1073–1076. 1986.PubMed/NCBI View Article : Google Scholar

43 

Langdown JV, Williamson D, Beresford CH, Gibb I, Taylor R and Deacon-Smith R: A new beta chain variant, Hb Tyne [beta 5(A2)Pro->Ser]. Hemoglobin. 18:333–336. 1994.PubMed/NCBI View Article : Google Scholar

44 

Joly P, Garcia C, Lacan P, Couprie N and Francina A: Two new hemoglobin variants: Hb Aix-Les-Bains [β5(A2)Pro→Leu; HBB:c.17 C>T] and Hb Dubai [α122(H5)His→Leu (α2); HBA2:c.368 A>T]. Hemoglobin. 35:147–151. 2011.PubMed/NCBI View Article : Google Scholar

45 

Karsegard J, Wicky J, Mensi N, Caulfield A and Philippe J: Spurious glycohemoglobin values associated with hydroxyurea treatment. Diabetes Care. 20:1211–1212. 1997.PubMed/NCBI View Article : Google Scholar

46 

Bry L, Chen PC and Sacks DB: Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 47:153–163. 2001.PubMed/NCBI

47 

Stim J, Shaykh M, Anwar F, Ansari A, Arruda JA and Dunea G: Factors determining hemoglobin carbamylation in renal failure. Kidney Int. 48:1605–1610. 1995.PubMed/NCBI View Article : Google Scholar

48 

Jaisson S, Leroy N, Guillard E, Desmons A and Gillery P: Analytical performances of the D-100TM hemoglobin testing system (Bio-Rad) for HbA1c assay. Clin Chem Lab Med. 53:1473–1479. 2015.PubMed/NCBI View Article : Google Scholar

49 

Weykamp CW, Miedema K, de Haan T and Doelman CJ: Carbamylated hemoglobin interference in glycohemoglobin assays. Clin Chem. 45:438–440. 1999.PubMed/NCBI

50 

Little RR, Rohlfing CL, Tennill AL, Hanson SE, Connolly S, Higgins T, Wiedmeyer CE, Weykamp CW, Krause R and Roberts W: Measurement of Hba(1C) in patients with chronic renal failure. Clin Chim Acta. 418:73–76. 2013.PubMed/NCBI View Article : Google Scholar

51 

Dolscheid-Pommerich RC, Kirchner S, Weigel C, Eichhorn L, Conrad R, Stoffel-Wagner B and Zur B: Impact of carbamylation on three different methods, HPLC, capillary electrophoresis and TINIA of measuring HbA1c levels in patients with kidney disease. Diabetes Res Clin Pract. 108:15–22. 2015.PubMed/NCBI View Article : Google Scholar

52 

Ng JM, Cooke M, Bhandari S, Atkin SL and Kilpatrick ES: The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease. Diabetes Care. 33:2310–2313. 2010.PubMed/NCBI View Article : Google Scholar

53 

Kilpatrick ES and Atkin SL: Using haemoglobin A(1c) to diagnose type 2 diabetes or to identify people at high risk of diabetes. BMJ. 348(g2867)2014.PubMed/NCBI View Article : Google Scholar

54 

Bridges KR, Schmidt GJ, Jensen M, Cerami A and Bunn HF: The acetylation of hemoglobin by aspirin. In vitro and in vivo. J Clin Invest. 56:201–207. 1975.PubMed/NCBI View Article : Google Scholar

55 

Unnikrishnan R, Anjana RM and Mohan V: Drugs affecting HbA1c levels. Indian J Endocrinol Metab. 16:528–531. 2012.PubMed/NCBI View Article : Google Scholar

56 

Camargo JL, Stifft J and Gross JL: The effect of aspirin and vitamins C and E on HbA1c assays. Clin Chim Acta. 372:206–209. 2006.PubMed/NCBI View Article : Google Scholar

57 

Weykamp CW, Penders TJ, Siebelder CW, Muskiet FA and van der Slik W: Interference of carbamylated and acetylated hemoglobins in assays of glycohemoglobin by HPLC, electrophoresis, affinity chromatography, and enzyme immunoassay. Clin Chem. 39:138–142. 1993.PubMed/NCBI

58 

Davie SJ, Gould BJ and Yudkin JS: Effect of vitamin C on glycosylation of proteins. Diabetes. 41:167–173. 1992.PubMed/NCBI View Article : Google Scholar

59 

Xu R, Zhang S, Tao A, Chen G and Zhang M: Influence of vitamin E supplementation on glycaemic control: A meta-analysis of randomised controlled trials. PLoS One. 9(e95008)2014.PubMed/NCBI View Article : Google Scholar

60 

Jain SK and Palmer M: The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic Biol Med. 22:593–596. 1997.PubMed/NCBI View Article : Google Scholar

61 

Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G and Lefebvre PJ: Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care. 14:68–72. 1991.PubMed/NCBI View Article : Google Scholar

62 

Shoff SM, Mares-Perlman JA, Cruickshanks KJ, Klein R, Klein BE and Ritter LL: Glycosylated hemoglobin concentrations and vitamin E, vitamin C, and beta-carotene intake in diabetic and nondiabetic older adults. Am J Clin Nutr. 58:412–416. 1993.PubMed/NCBI View Article : Google Scholar

63 

Weykamp CW, Penders TJ, Baadenhuijsen H, Muskiet FA, Martina W and van der Slik W: Vitamin C and glycohemoglobin. Clin Chem. 41:713–716. 1995.PubMed/NCBI

64 

Shah AD, Fox RK and Rushakoff RJ: Falsely decreased HbA1c in a type 2 diabetic patient treated with dapsone. Endocr Pract. 20:e229–e232. 2014.PubMed/NCBI View Article : Google Scholar

65 

Basavaraj GS, Gupta RD, Patel B, Jebasingh F, George AA, Peter D, George L, Paul TV and Thomas N: Erroneous reduction of HbA1c levels in patients with type 2 diabetes mellitus on dapsone treatment for Hansen's disease-a single-center retrospective cohort study. Indian J Dermatol Venereol Leprol. 88:519–522. 2022.PubMed/NCBI View Article : Google Scholar

66 

Mitchell K and Mukhopadhyay B: Drug-Induced Falsely Low A1C: Report of a case series from a diabetes clinic. Clin Diabetes. 36:80–84. 2018.PubMed/NCBI View Article : Google Scholar

67 

Diop ME, Bastard JP, Meunier N, Thévenet S, Maachi M, Capeau J, Pialoux G and Vigouroux C: Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients. AIDS Res Hum Retroviruses. 22:1242–1247. 2006.PubMed/NCBI View Article : Google Scholar

68 

Robertson M: Artificially low HbA1c associated with treatment with ribavirin. BMJ. 336(505)2008.PubMed/NCBI View Article : Google Scholar

69 

Gram-Hansen P, Eriksen J, Mourits-Andersen T and Olesen L: Glycosylated haemoglobin (HbA1c) in iron- and vitamin B12 deficiency. J Intern Med. 227:133–136. 1990.PubMed/NCBI View Article : Google Scholar

70 

Kim C, Bullard KM, Herman WH and Beckles GL: Association between iron deficiency and A1C Levels among adults without diabetes in the National Health and Nutrition Examination Survey, 1999-2006. Diabetes Care. 33:780–785. 2010.PubMed/NCBI View Article : Google Scholar

71 

Attard SM, Herring AH, Wang H, Howard AG, Thompson AL, Adair LS, Mayer-Davis EJ and Gordon-Larsen P: Implications of iron deficiency/anemia on the classification of diabetes using HbA1c. Nutr Diabetes. 5(e166)2015.PubMed/NCBI View Article : Google Scholar

72 

Cavagnolli G, Pimentel AL, Freitas PA, Gross JL and Camargo JL: Factors affecting A1C in non-diabetic individuals: Review and meta-analysis. Clin Chim Acta. 445:107–114. 2015.PubMed/NCBI View Article : Google Scholar

73 

Sundaram RC, Selvaraj N, Vijayan G, Bobby Z, Hamide A and Rattina Dasse N: Increased plasma malondialdehyde and fructosamine in iron deficiency anemia: Effect of treatment. Biomed Pharmacother. 61:682–685. 2007.PubMed/NCBI View Article : Google Scholar

74 

Guo W, Zhou Q, Jia Y and Xu J: Increased levels of glycated hemoglobin A1c and iron deficiency Anemia: A review. Med Sci Monit. 25:8371–8378. 2019.PubMed/NCBI View Article : Google Scholar

75 

Willekens FL, Roerdinkholder-Stoelwinder B, Groenen-Döpp YA, Bos HJ, Bosman GJ, van den Bos AG, Verkleij AJ and Were JM: Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation. Blood. 101:747–751. 2003.PubMed/NCBI View Article : Google Scholar

76 

Schnedl WJ, Wallner SJ, Piswanger C, Krause R and Lipp RW: Glycated hemoglobin and liver disease in diabetes mellitus. Wien Med Wochenschr. 155:411–415. 2005.PubMed/NCBI View Article : Google Scholar

77 

Bernstein RM, Freedman DB, Liyanage SP and Dandona P: Glycosylated haemoglobin in rheumatoid arthritis. Ann Rheum Dis. 41:604–606. 1982.PubMed/NCBI View Article : Google Scholar

78 

Pani LN, Korenda L, Meigs JB, Driver C, Chamany S, Fox CS, Sullivan L, D'Agostino RB and Nathan DM: Effect of aging on A1C levels in individuals without diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care. 31:1991–1996. 2008.PubMed/NCBI View Article : Google Scholar

79 

Ziemer DC, Kolm P, Weintraub WS, Vaccarino V, Rhee MK, Twombly JG, Narayan KM, Koch DD and Phillips LS: Glucose-independent, black-white differences in hemoglobin A1c levels: A cross-sectional analysis of 2 studies. Ann Intern Med. 152:770–777. 2010.PubMed/NCBI View Article : Google Scholar

80 

Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T and Barrett-Connor E: Diabetes Prevention Program Research Group. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the diabetes prevention program. Diabetes Care. 30:2453–2457. 2007.PubMed/NCBI View Article : Google Scholar

81 

Bergenstal RM, Gal RL, Connor CG, Gubitosi-Klug R, Kruger D, Olson BA, Willi SM, Aleppo G, Weinstock RS, Wood J, et al: Racial differences in the relationship of glucose concentrations and hemoglobin A1c Levels. Ann Intern Med. 167:95–102. 2017.PubMed/NCBI View Article : Google Scholar

82 

Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L, Pankow J, Coresh J and Brancati FL: Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med. 362:800–811. 2010.PubMed/NCBI

83 

Nakatani R, Murata T, Usui T, Moriyoshi K, Komeda T, Masuda Y, Kakita-Kobayashi M, Tagami T, Imashuku S, Kono S, et al: Importance of the average glucose level and estimated glycated hemoglobin in a diabetic patient with hereditary hemolytic Anemia and liver cirrhosis. Intern Med. 57:537–543. 2018.PubMed/NCBI View Article : Google Scholar

84 

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, et al: Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International diabetes federation diabetes atlas, 9(th) edition. Diabetes Res Clin Pract. 157(107843)2019.PubMed/NCBI View Article : Google Scholar

85 

American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care. 36 (Suppl 1):S11–S66. 2013.PubMed/NCBI View Article : Google Scholar

86 

Bergman M, Abdul-Ghani M, DeFronzo RA, Manco M, Sesti G, Fiorentino TV, Ceriello A, Rhee M, Phillips LS, Chung S, et al: Review of methods for detecting glycemic disorders. Diabetes Res Clin Pract. 165(108233)2020.PubMed/NCBI View Article : Google Scholar

87 

Campbell L, Pepper T and Shipman K: HbA1c: A review of non-glycaemic variables. J Clin Pathol. 72:12–19. 2019.PubMed/NCBI View Article : Google Scholar

88 

Xu A, Sun J, Li J, Chen W, Zheng R, Han Z and Ji L: Hb I: A α-globin chain variant causing unexpected HbA1c results. J Clin Lab Anal. 33(e22671)2019.PubMed/NCBI View Article : Google Scholar

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen Z, Shao L, Jiang M, Ba X, Ma B and Zhou T: Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review) Corrigendum in /10.3892/etm.2023.11885. Exp Ther Med 24: 707, 2022.
APA
Chen, Z., Shao, L., Jiang, M., Ba, X., Ma, B., & Zhou, T. (2022). Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review) Corrigendum in /10.3892/etm.2023.11885. Experimental and Therapeutic Medicine, 24, 707. https://doi.org/10.3892/etm.2022.11643
MLA
Chen, Z., Shao, L., Jiang, M., Ba, X., Ma, B., Zhou, T."Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review) Corrigendum in /10.3892/etm.2023.11885". Experimental and Therapeutic Medicine 24.6 (2022): 707.
Chicago
Chen, Z., Shao, L., Jiang, M., Ba, X., Ma, B., Zhou, T."Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review) Corrigendum in /10.3892/etm.2023.11885". Experimental and Therapeutic Medicine 24, no. 6 (2022): 707. https://doi.org/10.3892/etm.2022.11643
Copy and paste a formatted citation
x
Spandidos Publications style
Chen Z, Shao L, Jiang M, Ba X, Ma B and Zhou T: Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review) Corrigendum in /10.3892/etm.2023.11885. Exp Ther Med 24: 707, 2022.
APA
Chen, Z., Shao, L., Jiang, M., Ba, X., Ma, B., & Zhou, T. (2022). Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review) Corrigendum in /10.3892/etm.2023.11885. Experimental and Therapeutic Medicine, 24, 707. https://doi.org/10.3892/etm.2022.11643
MLA
Chen, Z., Shao, L., Jiang, M., Ba, X., Ma, B., Zhou, T."Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review) Corrigendum in /10.3892/etm.2023.11885". Experimental and Therapeutic Medicine 24.6 (2022): 707.
Chicago
Chen, Z., Shao, L., Jiang, M., Ba, X., Ma, B., Zhou, T."Interpretation of HbA1c lies at the intersection of analytical methodology, clinical biochemistry and hematology (Review) Corrigendum in /10.3892/etm.2023.11885". Experimental and Therapeutic Medicine 24, no. 6 (2022): 707. https://doi.org/10.3892/etm.2022.11643
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team